Diabetes News and Research

Latest Diabetes News and Research

Study estimates 1.3 million cancer deaths in Europe in 2011

There will be nearly 1.3 million deaths from cancer in Europe in 2011 according to predictions from a study published in the cancer journal, Annals of Oncology today.

8 Feb 2011

Australian teenagers could see declines in life expectancy and more heart problems: Study

Experts warn that the present generation of Australian teenagers could be the first with a decline in life expectancy and an increase in heart disease. This comes from the first comprehensive national study of young Australians since 1985 that shows that a quarter are overweight or obese.

8 Feb 2011

Avandia label revised as per FDA directive

Following the 2010 FDA directive, pharmaceutical manufacturer Glaxo-SmithKline announced this Monday that they have modified the label for diabetes drug rosiglitazone (Avandia). The new label restricts its use to patients already taking it or to those who have failed other antiglycemic drugs.

8 Feb 2011

New DGA urge Americans to reduce sodium intake, consume walnuts for 'good' fat

The 2010 U.S. Dietary Guidelines for Americans urge Americans to reduce their sodium intake, replace saturated and trans fats with the "good" fats and to lower cholesterol consumption.

8 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

8 Feb 2011

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

8 Feb 2011

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Transition Therapeutics Inc., a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended December 31, 2010.

8 Feb 2011

Study reports significant decline in second-generation medication use for dementia

As loved ones with dementia disappear into symptoms of aggression, agitation or delusions, families are left with few good medical solutions. A new generation of antipsychotic medications gained popularly in the 1990s because they avoided side effects such as Parkinson's syndrome associated with conventional antipsychotic medications used to treat dementia.

8 Feb 2011

Obesity rates double worldwide

The latest research has shown that obesity is on the rise worldwide and has actually doubled since 1980. On the other hand people in the developed countries have also managed to reduce their blood pressure and cholesterol levels. This comes from three new studies published online Feb. 3 in The Lancet.

7 Feb 2011

Gastric bypass surgery good for the heart in obese: Study

A new study has found that gastric bypass surgery, besides enabling severely obese people to lose weight, may also help their overly stressed hearts return to more normal function and appearance. The study appeared in the Feb. 8 issue of the Journal of the American College of Cardiology.

7 Feb 2011

Nutritional deficiencies among indigenous populations: two studies

They find iodine deficiency for the first time among an Aboriginal population in the NT. This deficiency was previously thought to occur only in the nation’s south-eastern states. The study involved nearly 400 teenagers of aboriginal origin living in remote as well as urban areas of the Darwin Health Region, which covers 120,000 km-square of the top end of the NT.

7 Feb 2011

Viewpoints: (Still) Debating health law's constitutionality; Food labels; Lawmakers' abortion divide

For state governments, the bill presents huge new costs, as we are required to enroll 15 million to 20 million more people in our Medicaid systems. ... Perhaps worse, the law expects to conscript the states as its agents in its takeover of health care. It assumes that we will set up and operate its new insurance "exchanges" for it (Indiana Gov. Mitch Daniels, 2/7).

7 Feb 2011

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

Harbor BioSciences, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today announced it is closing the clinical sites of its U.S.-based Phase I/IIa clinical trial with Apoptone® (HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.

7 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

7 Feb 2011

Sugary snacks and lax dental hygiene put kids at risk for tooth decay

While the most prevalent focus of February is on Valentine's sweethearts, parents are well advised to also focus on the proverbial sweet tooth - particularly when it comes to their children. That's because February is National Children's Dental Health Month, an ideal time - according to Health Net, Inc. - for moms and dads to make sure that sugary snacks, as well as lax dental hygiene - aren't putting their kids at risk for tooth decay.

7 Feb 2011

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

EpiCept Corporation today announced positive results from a Phase IIb trial evaluating the efficacy and safety of EpiCept NP-1 in chemotherapy-induced peripheral neuropathy. EpiCept NP-1 is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

7 Feb 2011

Diabetes Management – a new journal addressing the management issues of a complex disease

Future Medicine Ltd has today announced the launch of Diabetes Management – a new bimonthly title presenting findings, analyses and commentaries on the battle with Type 1 and Type 2 diabetes. Diabetes Management is published by Future Medicine Ltd (UK, London) renowned for its collection of journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.

6 Feb 2011

Super spinach really boosts power: Study

Scientists have found out the basis of what we already knew – spinach is good for us. They have found that it is the nitrates in spinach that are abundant in all green leafy vegetables that boosts the powerhouses in cells which provide energy. In fact a single helping of spinach is enough to increase the efficiency of mitochondria. These are small bean-shaped bodies which fuel cell activity and growth. This explains how Popeye the Sailor man – a famous cartoon character, who dates back to the 1930s, gets his power from a can of spinach.

6 Feb 2011

Patient need to share medication side effects with health care team: Retired family doctor

"I had a wonderful gentleman patient who had resistant blood pressure," recalls Vicki Koenig, M.D., a retired family doctor in Exmore, VA. "When he came for a blood pressure check on the latest new med and it was great, I was ecstatic. Then he said, 'But I notice my urine's a little dark.' His was one of the first cases of fatal liver complications from this medication."

5 Feb 2011

Studies show growing problems of non-communicable diseases in low-, middle-income countries

Obesity rates have doubled worldwide since 1980," according to a study published Friday as part of a series in the Lancet that also looked at global blood pressure and cholesterol trends, ABC News reports (Carolo, 2/4).

5 Feb 2011

Diabetes News and Research

Latest Diabetes News and Research

Study estimates 1.3 million cancer deaths in Europe in 2011

Australian teenagers could see declines in life expectancy and more heart problems: Study

Avandia label revised as per FDA directive

New DGA urge Americans to reduce sodium intake, consume walnuts for 'good' fat

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Study reports significant decline in second-generation medication use for dementia

Obesity rates double worldwide

Gastric bypass surgery good for the heart in obese: Study

Nutritional deficiencies among indigenous populations: two studies

Viewpoints: (Still) Debating health law's constitutionality; Food labels; Lawmakers' abortion divide

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

Sugary snacks and lax dental hygiene put kids at risk for tooth decay

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Diabetes Management – a new journal addressing the management issues of a complex disease

Super spinach really boosts power: Study

Patient need to share medication side effects with health care team: Retired family doctor

Studies show growing problems of non-communicable diseases in low-, middle-income countries

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Diabetes News and Research

Latest Diabetes News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in